Skip to main content
. 2016 Dec 14;19:10–12. doi: 10.1016/j.gore.2016.12.003

Fig. 2.

Fig. 2

Representative CT scans demonstrating activity of TDM-1. Left panel: Pretreatment image with baseline measurement of the target recurrent/metastatic tumor deposit (i.e., mass growing in the rectus muscle). Middle panel: regression of the metastatic tumor deposits described above one month after TDM-1 treatment initiation. Right panel: complete regression of the metastatic tumor deposits described above three months after treatment initiation with TDM-1.